HT has a specific role in women with premature menopause, and should be considered until the age of natural menopause (51 years). It has numerous beneficial effects, if prescribed soon after the menopause, when the “window of opportunity” potentiates its beneficial impact on likely healthy organs and tissue.
The need to continue with treatment and the indications for HT should be reviewed regularly when used in the long term. Constant updating is required in the rapidly evolving field of menopausal management.